FairJourney Biologics
Daniela Teixeira started their work experience in 2001 as a PhD student at the University of Porto/University of Arizona, where they worked until 2008. In 2008, they joined Ablynx as an Associate Scientist and stayed with the company until 2012. From 2012 to 2016, Daniela worked at FairJourney Biologics as a Scientist-Team Leader. Daniela then became a Senior Scientist at the same company from 2016 to 2017. In July 2017, they took on the role of COO at FairJourney Biologics, where they currently work.
From 1995 to 2000, Daniela Teixeira attended Universidade do Porto, where they earned a degree in Biochemistry. No specific field of study is specified.
FairJourney Biologics
FairJourney Biologics is a privately established company with an outstanding track record of biotech and biopharmaceutical partners (Merus, argenX, BMS, Bayer, among others), offering a range of assets and services on antibody discovery, engineering, production, characterization up to cell line development stages. Our naïve and immune libraries from humans, rodents and llama, together with our know-how and internal technological development allow us to contribute to the pipeline of our partners on complex targets, leading to 14 known antibodies in the clinic. More recently, FairJourney Biologics has been joined by specialists in the field such as Tariq Ghayur (formerly Abbvie) and Rene Hoet (formerly Bayer), creating a panel of available scientists as service to support complex antibody projects. From target validation up to cell line development and pre-CMC reporting, FairJourney Biologics is a one stop shop leader in antibody services. As of 2022, the company has a headcount of above 200 staff members and a track record of more than 800 projects on a variety of areas.